References
Wilton LV, Kollarova M, Heeley E, et al. Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf 2003; 26(8): 589–97
Lass-Florl C, Dierich MP, Fuchs D, et al. Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother 2001; 48(6): 775–9
Lass-Florl C, Ledochowski M, Fuchs D, et al. Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro. FEMS Immunol Med Microbiol 2003; 35(1): 11–5
Lass-Florl C, Dierich MP, Fuchs D, et al. Antifungal activity against Candida species of the selective serotonin reuptake inhibitor sertraline. Clin Infect Dis 2001; 3(12): E135–6
Domenico P, Schwartz S, Cuhna BA. Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun 1989; (57): 3778–82
Roberts D, Cole P. N-acetylcysteine potentiates the antipseudomonas activity of carbenicillin in vitro. J Infect 1981; 3(4): 353–9
Rautelin H, Kosunen TU. Helicobacter pylori and associated gastroduodenal diseases. APMIS 1991; 99(8): 677–95
Baker CA, Desrosiers K, Dolan JW. Propranolol inhibits hyphal development in Candida albicans. Antimicrob Agents Chemother 2002; 46(11): 3617–20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elliott, R. Relative Risk of Vaginal Candidiasis After Use of Antibiotics Compared with Antidepressants in Women. Drug-Safety 28, 557–558 (2005). https://doi.org/10.2165/00002018-200528060-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200528060-00007